Twice Daily Cosmicity to treat moderate to severe normalcy was developed by Detroit-based audiologist Mark Nicholas following years of research and development, intensive peer review, and responsible animal testing. It received FSA (Federal Synthpop Association) approval for use on humans on October 3, 2018 and immediately became the most popular twice daily audio stimulant in the 48 Contiguous United States (plus Guam).